EUVIMEDEUVIMED entdecken
Crossref

Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[ b ]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators

Hager R Nofal, Ahmed A Al-Karmalawy, Ayman Abo Elmaaty, Mahmoud F Ismail, Ali Khalil Ali, Eslam M Abbass

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Hager R Nofal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt. Hauptthemen laut MEDLINE: Thiophenes, Topoisomerase I Inhibitors, Topoisomerase II Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of tetrahydrobenzo[ b ]thiophene derivatives was designed and synthesized as dual topoisomerase (Topo) I/II inhibitors implicating potential DNA intercalation. Ethyl‐2‐amino‐3‐cyano‐4,5,6,7‐tetrahydrobenzo[ b ]thiophene‐4‐carboxylate ( 1 ) was prepared by modification of the Gewald reaction procedure using a Fe 2 O 3 nanocatalyst and then it was used as a building block for the synthesis of tetrahydrobenzo[ b ]thiophene candidates ( 2–14 ). Interestingly, compound 14 showed the best cytotoxic potential against hepatocellular, colorectal, and breast cancer cell lines (IC 50 = 7.79, 8.10, and 3.53 µM), respectively, surpassing doxorubicin at breast cancer (IC 50 = 4.17 µM). Meanwhile, the Topo I and II inhibition assay displayed that compound 3 could exhibit the best inhibitory potential among the investigated candidates (IC 50 = 25.26 and 10.01 nM), respectively, in comparison to camptothecin (IC 50 = 28.34 nM) and doxorubicin (IC 50 = 11.01 nM), as reference standards. In addition, the DNA intercalation assay showed that compound 14 could display the best binding affinity with an IC 50 value of 77.82 µM in comparison to doxorubicin (IC 50 = 58.03 µM). Furthermore, cell cycle and apoptosis analyses described that compound 3 prompts the G1 phase arrest in michigan cancer foundation‐7 cancer cells and increases the apoptosis ratio by 29.31% with respect to untreated cells (2.25%). Additionally, the conducted molecular docking assured the promising binding of the investigated members toward Topo I and II with potential DNA intercalation. Accordingly, the synthesized compounds could be treated as promising anticancer candidates for future optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesTopoisomerase I InhibitorsTopoisomerase II InhibitorsAntineoplastic AgentsDrug DesignDrug Screening Assays, AntitumorIntercalating AgentsHumansStructure-Activity RelationshipMolecular StructureMolecular Docking SimulationDose-Response Relationship, DrugCell Line, TumorCell ProliferationDNA Topoisomerases, Type IIApoptosisDNADNA Topoisomerases, Type IPharmacophore

Stichwörter der Autor:innen

DNA intercalationTopo ITopo IImultitarget rationaletetrahydrobenzo[b]thiophene

Substanzen

ThiophenesTopoisomerase I InhibitorsTopoisomerase II InhibitorsAntineoplastic AgentsIntercalating AgentsDNA Topoisomerases, Type IIDNADNA Topoisomerases, Type I

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said, Egypt.

Förderung

  • None

Zitieren

APA

Nofal, H. R., Al-Karmalawy, A. A., Elmaaty, A. A., Ismail, M. F., Ali, A. K., & Abbass, E. M. (2024). Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[ b ]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400217

Vancouver

Nofal HR, Al-Karmalawy AA, Elmaaty AA, Ismail MF, Ali AK, Abbass EM. Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[ b ]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400217

BibTeX
@article{Nofal2024,
  author = {Nofal, Hager R and Al-Karmalawy, Ahmed A and Elmaaty, Ayman Abo and Ismail, Mahmoud F and Ali, Ali Khalil and Abbass, Eslam M},
  title = {Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[ b ]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400217}
}
Kostenlos starten →